Melatonin enhances the human mesenchymal stem cells motility via melatonin receptor 2 coupling with Gaq in skin wound healing

Journal of Pineal Research

Volumn 57, Issue 4, 2014, Pages 393-407

  Lee, Sei Jung ^a   Jung, Young Hyun ^a   Oh, Sang Yub ^a   Yun, Seung Pil ^a   Han, Ho Jae ^a  

^a Seoul National University   (South Korea)

Author keywords

Melatonin; Melatonin receptor 2; Motility; Mouse skin wound; Umbilical cord blood derived mesenchymal stem cells

Indexed keywords

ANTIOXIDANT; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MELATONIN; MELATONIN RECEPTOR;

ANIMAL; CELL MOTION; CONFOCAL MICROSCOPY; DRUG EFFECTS; GENETIC TRANSFECTION; HUMAN; IMMUNOPRECIPITATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PHYSIOLOGY; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; WESTERN BLOTTING; WOUND HEALING; XENOGRAFT;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CELL MOVEMENT; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HETEROGRAFTS; HUMANS; IMMUNOPRECIPITATION; MELATONIN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICROSCOPY, CONFOCAL; RECEPTORS, MELATONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TRANSFECTION; WOUND HEALING;

EID: 84918772976     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12179     Document Type: Article

References (72)

1. RORTH P. Collective cell migration. Annu Rev Cell Dev Biol 2009; 25:407-429.
2. RODERO MP, KHOSROTEHRANI K. Skin wound healing modulation by macrophages. Int J Clin Exp Pathol 2010; 3:643-653.
3. WU Y, CHEN L, SCOTT PG et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007; 25:2648-2659.
4. WU Y, ZHAO RC, TREDGET EE. Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells 2010; 28:905-915.
5. PELED A, PETIT I, KOLLET O et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283:845-848.
6. SON BR, MARQUEZ-CURTIS LA, KUCIA M et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 2006; 24:1254-1264.
7. LEE MJ, JEON ES, LEE JS et al. Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells. J Cell Biochem 2008; 104:499-510.
8. FU X, HAN B, CAI S et al. Migration of bone marrow-derived mesenchymal stem cells induced by tumor necrosis factoralpha and its possible role in wound healing. Wound Repair Regen 2009; 17:185-191.
9. ACUNA-CASTROVIEJO D, ESCAMES G, VENEGAS C et al. Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci 2014; 71:2997-3025.
10. VENEGAS C, GARCIA JA, ESCAMES G et al. Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52:217-227.
11. SLOMINSKI A, BAKER J, ROSANO TG et al. Metabolism of serotonin to N-acetylserotonin, melatonin, and 5-methoxytryptamine in hamster skin culture. J Biol Chem 1996; 271:12281-12286.
12. SLOMINSKI A, PISARCHIK A, SEMAK I et al. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 2002; 16:896-898.
13. SLOMINSKI A, TOBIN DJ, ZMIJEWSKI MA et al. Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol Metab 2008; 19:17-24.
14. DUBOCOVICH ML, MARKOWSKA M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27:101-110.
15. SLOMINSKI RM, REITER RJ, SCHLABRITZ-LOUTSEVITCH N et al. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol 2012; 351:152-166.
16. SLOMINSKI A, FISCHER TW, ZMIJEWSKI MA et al. On the role of melatonin in skin physiology and pathology. Endocrine 2005; 27:137-148.
17. SLOMINSKI A, PISARCHIK A, ZBYTEK B et al. Functional activity of serotoninergic and melatoninergic systems expressed in the skin. J Cell Physiol 2003; 196:144-153.
18. HARDELAND R. Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms. J Pineal Res 2013; 55:325-356.
19. GALANO A, TAN DX, REITER RJ. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54:245-257.
20. PUGAZHENTHI K, KAPOOR M, CLARKSON AN et al. Melatonin accelerates the process of wound repair in full-thickness incisional wounds. J Pineal Res 2008; 44:387-396.
21. TOCHARUS C, PURIBORIBOON Y, JUNMANEE T et al. Melatonin enhances adult rat hippocampal progenitor cell proliferation via ERK signaling pathway through melatonin receptor. Neuroscience 2014; 275C:314-321.
22. FU J, ZHAO SD, LIU HJ et al. Melatonin promotes proliferation and differentiation of neural stem cells subjected to hypoxia in vitro. J Pineal Res 2011; 51:104-112.
23. LIU X, GONG Y, XIONG K et al. Melatonin mediates protective effects on inflammatory response induced by interleukin-1 beta in human mesenchymal stem cells. J Pineal Res 2013; 55:14-25.
24. GAO S, WANG ZL, DI KQ et al. Melatonin improves the reprogramming efficiency of murine-induced pluripotent stem cells using a secondary inducible system. J Pineal Res 2013; 55:31-39.
25. LUCHETTI F, CANONICO B, BARTOLINI D et al. Melatonin regulates mesenchymal stem cell differentiation: a review. J Pineal Res 2014; 56:382-397.
26. CHEN HH, LIN KC, WALLACE CG et al. Additional benefit of combined therapy with melatonin and apoptotic adiposederived mesenchymal stem cell against sepsis-induced kidney injury. J Pineal Res 2014; 57:16-32.
27. QIAO C, XU W, ZHU W et al. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 2008; 32:8-15.
28. YANG SE, HA CW, JUNG M et al. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy 2004; 6:476-486.
29. le BLANC K, TAMMIK L, SUNDBERG B et al. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57:11-20.
30. YUN SP, LEE SJ, OH SY et al. Reactive oxygen species induce MMP12-dependent degradation of collagen 5 and fibronectin to promote the motility of human umbilical cord-derived mesenchymal stem cells. Br J Pharmacol 2014; 171:3283-3297.
31. YUN SP, LEE SJ, JUNG YH et al. Galectin-1 stimulates motility of human umbilical cord blood-derived mesenchymal stem cells by downregulation of smad2/3-dependent collagen 3/5 and upregulation of NF-jB-dependent fibronectin/laminin 5 expression. Cell Death Dis 2014; 5:e1049.
32. RICHTER HG, HANSELL JA, RAUT S et al. Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J Pineal Res 2009; 46:357-364.
33. LANOIX D, GUERIN P, VAILLANCOURT C. Placental melatonin production and melatonin receptor expression are altered in preeclampsia: new insights into the role of this hormone in pregnancy. J Pineal Res 2012; 53:417-425.
34. MILLER SL, YAWNO T, ALERS NO et al. Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction. J Pineal Res 2014; 56:283-294.
35. KISHIBE M, BANDO Y, TANAKA T et al. Kallikrein-related peptidase 8-dependent skin wound healing is associated with upregulation of kallikrein-related peptidase 6 and PAR2. J Invest Dermatol 2012; 132:1717-1724.
36. LEE KB, CHOI J, CHO SB et al. Topical embryonic stem cells enhance wound healing in diabetic rats. J Orthop Res 2011; 29:1554-1562.
37. CHEN L, TREDGET EE, LIU C et al. Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS ONE 2009; 4:e7119.
38. BENICHOU G, YAMADA Y, YUN SH et al. Immune recognition and rejection of allogeneic skin grafts. Immunotherapy 2011; 3:757-770.
39. UCCELLI A, PISTOIA V, MORETTA L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 2007; 28:219-226.
40. PHAM PV, VU NB, PHAM VM et al. Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells. J Transl Med 2014; 12:56.
41. CHIENG-YANE P, BOCQUET A, LETIENNE R et al. Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor alpha and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells. J Pharmacol Exp Ther 2011; 336:643-651.
42. PARK JH, HAN HJ. Caveolin-1 plays important role in EGFinduced migration and proliferation of mouse embryonic stem cells: involvement of PI3K/Akt and ERK. Am J Physiol Cell Physiol 2009; 297:C935-C944.
43. BRADFORD MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
44. SHARMA R, MCMILLAN CR, NILES LP. Neural stem cell transplantation and melatonin treatment in a 6-hydroxydopamine model of Parkinson's disease. J Pineal Res 2007; 43:245-254.
45. PANDI-PERUMAL SR, TRAKHT I, SRINIVASAN V et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008; 85:335-353.
46. REITER RJ, TAN DX. What constitutes a physiological concentration of melatonin? J Pineal Res 2003; 34:79-80.
47. SOTTHIBUNDHU A, PHANSUWAN-PUJITO P, GOVITRAPONG P. Melatonin increases proliferation of cultured neural stem cells obtained from adult mouse subventricular zone. J Pineal Res 2010; 49:291-300.
48. ZHANG L, SU P, XU C et al. Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPAR? expression and enhancing Runx2 expression. J Pineal Res 2010; 49:364-372.
49. PESCHKE E, MUHLBAUER E. New evidence for a role of melatonin in glucose regulation. Best Pract Res Clin Endocrinol Metab 2010; 24:829-841.
50. CHEN L, HE X, ZHANG Y et al. Melatonin receptor type 1 signals to extracellular signal-regulated kinase 1 and 2 via Gi and Gs dually coupled pathways in HEK-293 cells. Biochemistry 2014; 53:2827-2839.
51. MORISHITA R, UEDA H, ITO H et al. Involvement of Gq/11 in both integrin signal-dependent and-independent pathways regulating endothelin-induced neural progenitor proliferation. Neurosci Res 2007; 59:205-214.
52. AHN S, WEI H, GARRISON TR et al. Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by ?-arrestins 1 and 2. J Biol Chem 2004; 279:7807-7811.
53. GERDIN MJ, MASANA MI, RIVERA-BERMUDEZ MA et al. Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin. FASEB J 2004; 18:1646-1656.
54. ETIENNE-MANNEVILLE S, HALL A. Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKC?. Cell 2001; 106:489-498.
55. LAUDANNA C, SORIO C, TECCHIO C et al. Motility analysis of pancreatic adenocarcinoma cells reveals a role for the atypical zeta isoform of protein kinase C in cancer cell movement. Lab Invest 2003; 83:1155-1163.
56. FORDE S, TYE BJ, NEWEY SE et al. Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells. Blood 2007; 109:1825-1833.
57. BRUCE-STASKAL PJ, BOUTON AH. PKC-dependent activation of FAK and src induces tyrosine phosphorylation of Cas and formation of Cas-Crk complexes. Exp Cell Res 2001; 264:296-306.
58. YUN SP, RYU JM, HAN HJ. Involvement of ?1-integrin via PIP complex and FAK/paxillin in dexamethasone-induced human mesenchymal stem cells migration. J Cell Physiol 2011; 226:683-692.
59. MIERKE CT. The role of focal adhesion kinase in the regulation of cellular mechanical properties. Phys Biol 2013; 10:065005.
60. TURNER CE. Paxillin and focal adhesion signalling. Nat Cell Biol 2000; 2:E231-E236.
61. BELLIS SL, MILLER JT, TURNER CE. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J Biol Chem 1995; 270:17437-17441.
62. HALL A. Rho GTPases and the actin cytoskeleton. Science 1998; 279:509-514.
63. ORTIZ-LOPEZ L, MORALES-MULIA S, RAMIREZ-RODRIGUEZ G et al. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res 2009; 46:15-21.
64. GOMEZ-PINILLA PJ, GOMEZ MF, SWARD K et al. Melatonin restores impaired contractility in aged guinea pig urinary bladder. J Pineal Res 2008; 44:416-425.
65. TANG DD, ZHANG W, GUNST SJ. The adapter protein CrkII regulates neuronal Wiskott-Aldrich syndrome protein, actin polymerization, and tension development during contractile stimulation of smooth muscle. J Biol Chem 2005; 280:23380-23389.
66. INSALL RH, MACHESKY LM. Actin dynamics at the leading edge: from simple machinery to complex networks. Dev Cell 2009; 17:310-322.
67. YANG FC, ATKINSON SJ, GU Y et al. Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization. Proc Natl Acad Sci USA 2001; 98:5614-5618.
68. PARK SS, KIM MO, YUN SP et al. C16-Ceramide-induced F-actin regulation stimulates mouse embryonic stem cell migration: involvement of N-WASP/Cdc42/Arp2/3 complex and cofilin-1/?-actinin. Biochim Biophys Acta 2013; 1831: 350-360.
69. YUN SP, RYU JM, KIM MO et al. Rapid actions of plasma membrane estrogen receptors regulate motility of mouse embryonic stem cells through a profilin-1/cofilin-1-directed kinase signaling pathway. Mol Endocrinol 2012; 26:1291-1303.
70. MENKE A, GIEHL K. Regulation of adherens junctions by Rho GTPases and p120-catenin. Arch Biochem Biophys 2012; 524:48-55.
71. KONAKAHARA S, OHASHI K, MIZUNO K et al. CD29 integrin-and LIMK1/cofilin-mediated actin reorganization regulates the migration of haematopoietic progenitor cells underneath bone marrow stromal cells. Genes Cells 2004; 9:345-358.
72. ARAKI N, HATAE T, YAMADA T et al. Actinin-4 is preferentially involved in circular ruffling and macropinocytosis in mouse macrophages: analysis by fluorescence ratio imaging. J Cell Sci 2000; 113(Pt 18):3329-3340.